Assessment of dependence potential is required for drugs that affect the central nervous system. INA performs highly accurate drug dependence studies based on a wealth of experience and achievements accumulated over many years. Japanese Ministry of Health regulations, and the EMEA/CHMP Guideline on the Non-Clinical Investigation of the Dependence Potential of Medicinal Products (March 23, 2006), are strictly followed to ensure the highest quality data possible.
Consulting services for your development needs are also available.

1. Psychological dependence
2. Physical dependence